Cta Pharma Co.ltd

Country/Region: China     State/Province: Shanghai

Main Products: Entecavir, Fenafibrate, 6-APA, 7-MPCA, Azithromycin, Amoxicillin, Ceftazidime, Cefoxitin Sodium, Cefonicid Sodium, Cefodroxil, Cephradine, Gentamicin

Company Introduction
Entecavir,fenafibrate,6-APA,7-MPCA,Azithromycin,Amoxicillin,Ceftazidime, Cefoxitin sodium, Cefonicid Sodium, Cefodroxil, Cephradine,Gentamicin
Company Overview

Business Type: Exporter, Trader

Year Established: 2007

Employees: 51 - 100 People

Plant Area: 30,000-50,000 square meters

Contact Information

Fax: 86-756-2233525

Business Information

Main Markets: South America 12% Africa 12% Eastern Asia 10% Domestic Market 9% North America 10% Eastern Europe 8% Southern Europe 8% Mid East 8% Northern Europe 8% Oceania 15%

Trade Capacity: FOB, EXW, DEQ

Contract Manufacturing: OEM Service Offered Design Service Offered

Nearest Port: Shanghai

Trade & Financial Information

Annual Revenue: confidential

Total Revenue: US$5 Million - US$10 Million

Export Revenue: Above US$100 Million

Annual Output: confidential

Registered Capital: US$2.5 Million - US$5 Million

Export Percentage: 11% - 20%

Payment Modes: USD, EUR, CNY

Lead Time: 35 days

Import/Export Mode: Have Own Export License

Product Showcase
Entecavir
fenafibrate
6-APA
7-MPCA
Azithromycin
Amoxicillin
Ceftazidime
Cefoxitin sodium
Cefonicid Sodium
Cefodroxil
Cephradine
Gentamicin

CL-Link > Health & Medicines in China Health & Medicines in Shanghai Medicines in China Medicines in Shanghai Amoxicillin in China Amoxicillin in Shanghai